Braden Michael Leonard, 10% Owner at Reneo Pharmaceuticals, Inc. (RPHM), bought 543,652 shares at $1.39 ($760K) on 2024-08-13, disclosed to the SEC on 2024-08-14.
Open-market purchase of $760k RPHM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.39 | 171,339 | $238K | 31.3% |
| 2 | $1.39 | 171,339 | $238K | 31.3% |
| 3 | $1.41 | 100,487 | $142K | 18.7% |
| 4 | $1.41 | 100,487 | $142K | 18.7% |
| Total | $1.40 avg | 543,652 | $760K | 100% |
| Filing → |
| ADVM | SELL | 2025-12-03 | $3.6M | — | Filing → |
| ASTC | SELL | 2025-10-07 | $3.2M | — | Filing → |
| ANTX | SELL | 2025-06-16 | $436K | — | Filing → |